Search results

FOXP3 mentioned in these (though I think downregulated in some) — Upregulation of olfactory receptors and neuronal-associated genes highlights complex immune and neuronal dysregulation in Long COVID patients (2025) Immunological profiling in long COVID: overall low grade inflammation and...

Mostly the authors of Integrated immune, hormonal, and transcriptomic profiling reveals sex-specific dysregulation in long COVID patients with ME/CFS (2025) as well as Exploring the role of galectin-9 and artemin as biomarkers in long COVID with chronic fatigue syndrome: links to inflammation...

SARS-CoV-2 reinfections and subsequent risk of hospital-diagnosed post-acute sequelae in Denmark 2020–2022: a nationwide cohort study BACKGROUND Post-acute sequelae of COVID-19 (PASC), or long COVID, are a public health concern. While most recover from SARS-CoV-2 infections within weeks, some...

Previous publications etc listed at ORCID: Michael S. Zandi PhD FRCP

Pierre Kory features (a little) in this breakdown of a scientists vs anti-vaxxers debate, along with Steve Kirsch.

Short report. Small numbers.

Non-invasive electrodiagnostic testing for small fibre neuropathy in long COVID-19 Anthony Khoo; Kisani Manuel; Tracy Ng; Maria Crotty BACKGROUND Long COVID-19 is associated with a diverse range of debilitating neuropathic and autonomic symptoms that may indicate small fibre neuropathy (SFN)...

Responding to the question in the News from Scotland thread. Co-author of two recent papers — Daily stress and worry are additional triggers of symptom fluctuations in individuals living with Long COVID: results from an intensive longitudinal cohort study (2025) What Can We Learn Four Years...

She posted that she'll be interviewed on BBC Radio Scotland today (?) so we may get a better sense. She may be OK but there is certainly cause for circumspection, given these posts four and three months ago —

(PMA is a positive control.)

NET Biomarkers in COVID-19 and Post-COVID Syndrome: a Comprehensive Analysis SARS-CoV-2 triggers immune responses, including neutrophil activation and neutrophil extracellular trap (NET) release, contributing to COVID-19 severity. A significant proportion of patients experience persistent or...

Now published as — Indistinguishable mitochondrial phenotypes after exposure of healthy myoblasts to myalgic encephalomyelitis/chronic fatigue syndrome or control serum Audrey A Ryback; Charles B Hillier; Camila M Loureiro; Chris P Ponting; Caroline F Dalton Myalgic Encephalomyelitis (ME) /...

Off topic but EMJReviews.com (and its sibling American Medical Journal) do not look like legitimate biomedical organisations. See https://www.emjreviews.com/about-us/ and the founder's podcast https://www.emjreviews.com/podcast-gold-with-gore/ I was followed by them and the American version on...

Auto-translating three that piqued my interest: multi-modality muscle evaluation, including in/out of PEM, and MRI evaluation of cerebral blood flow with lower body negative pressure —

Modifying table 1 and removing the last column for relevance to schizophrenia. Term Typical use in literature Advantages Limitations Neuroinflammation Classical CNS inflammatory diseases with four hallmarks Well-known, cross-disciplinary clarity Suggests high-grade pathology; may mislead in...

It's hard to find small quotes, the entire paper looks very good and on a quick skim I suspect Jonathan could easily have been an author (we'll see if he agrees). After discussing the meanings of inflammation in the CNS context and particularly with reference to in vivo and post-mortem findings...

If it's even slightly helpful, I downloaded the auto-generated subtitles (via DownSub) and removed the ums, ahhs, errs etc. (It's still a lot of text though).

Research letter responding to this paper SARS-CoV-2 spike protein can bind fibrinogen, but does not alter plasma fibrin formation, clot structure, or lysis (2026)

That control was evaluated for people with psychosis. Ref is The Credibility and Acceptability of Befriending as a Control Therapy in a Randomized Controlled Trial of Cognitive Behaviour Therapy for Acute First Episode Psychosis (2006) —